← Back to Search
Preparation And Characterization Of Low-molecular-weight Heparin/protamine Nanoparticles (LMW-H/P NPs) As FGF-2 Carrier
Y. Mori, S. Nakamura, S. Kishimoto, M. Kawakami, S. Suzuki, T. Matsui, M. Ishihara
Published 2010 · Materials Science, Medicine
Download PDFAnalyze on Scholarcy
We produced low-molecular-weight heparin/protamine nanoparticles (LMW-H/P NPs) as a carrier for heparin-binding growth factors, such as fibroblast growth factor-2 (FGF-2). A mixture of low-molecular-weight heparin (MW: about 5000 Da, 6.4 mg/mL) and protamine (MW: about 3000 Da, 10 mg/mL) at a ratio of 7:3 (vol:vol) yields a dispersion of microparticles (1–6 μm in diameter). In this study, diluted low-molecular-weight heparin solution in saline (0.32 mg/mL) mixed with diluted protamine (0.5 mg/mL) at a ratio at 7:3 (vol:vol) resulted in soluble nanoparticles (112.5 ± 46.1 nm in diameter). The generated NPs could be then stabilized by adding 2 mg/mL dextran (MW: 178–217 kDa) and remained soluble after lyophilization of dialyzed LMW-H/P NP solution. We then evaluated the capacity of LMW-H/P NPs to protect activity of FGF-2. Interaction between FGF-2 and LMW-H/P NPs substantially prolonged the biological half-life of FGF-2. Furthermore, FGF-2 molecules were protected from inactivation by heat and proteolysis in the presence of LMW-H/P NPs.
This paper references
In-laboratory removal of femoral sheath following protamine administration in patients having intracoronary stent implantation.
M. Pan (1997)
Complex formation between polyelectrolytes in dilute aqueous solution. Polymer
L Webster (1997)
Human stem cell factor (SCF) is a heparin-binding cytokine.
S. Kishimoto (2009)
The interaction of chitosan with fibroblast growth factor-2 and its protection from inactivation.
K. Masuoka (2005)
Polyelectrolytes and Nanoparticles
J. Koetz (2007)
Nonstoichiometric polyelectrolyte complexes: A mathematical model and some experimental results
E. Nordmeier (1999)
Controlled release of fibroblast growth factor-2 from an injectable 6-O-desulfated heparin hydrogel and subsequent effect on in vivo vascularization.
S. Nakamura (2006)
Complex Formation between Bovine Serum Albumin and Strong Polyelectrolytes: Effect of Polymer Charge Density
K. Mattison (1998)
Heparan sulfate: a piece of information.
M. Salmivirta (1996)
Chitosan-chondroitin sulfate and chitosan-hyaluronate polyelectrolyte complexes. Physico-chemical aspects
A. Denuzière (1996)
Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (Fragmin) at the site of activation of the coagulation system in man.
M. Wolzt (1995)
Effect of protein charge heterogeneity in protein-polyelectrolyte complexation. Macromolecules
JM Park (1992)
Particle size of liposomes influences dermal delivery of substances into skin.
D. Verma (2003)
Heparin protects basic and acidic FGF from inactivation
D. Gospodarowicz (1986)
Heparin and lowmolecular heparin, mechanisms of action, phormacokinetics, dosing, monitoring, efficacy, and safety
J Hirsh (2001)
Structural features in heparin that interact with VEGF165 and modulate its biological activity.
K. Ono (1999)
Structure and Function of Heparin and Heparan Sulfate; Heparinoid Library and Modification of FGF-Activities
M. Ishihara (1998)
Effects of protein charge heterogeneity in protein-polyelectrolyte complexation
J. Park (1992)
Characterization and detection of polyanions by direct polyelectrolyte titration
Karl‐Heinz Wassmer (1991)
Heparin and lowmolecular heparin, mechanisms of action, phormacokinetics, dosing, monitoring, efficacy, and safety. Chest
J Hirsh (2001)
In Vitro Gene Delivery by pDNA/Chitosan Complexes Coated with Anionic PEG Derivatives that Have a Sugar Side Chain
Mayu Hashimoto (2008)
Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety.
J. Hirsh (2001)
Vascularization in vivo caused by the controlled release of fibroblast growth factor-2 from an injectable chitosan/non-anticoagulant heparin hydrogel.
M. Fujita (2004)
Complex formation between polyelectrolytes in dilute aqueous solution
Lee F. Webster (1997)
Polyelectrolyte complexes. I. Synthesis and characterization of some insoluble polyanion-polycation complexes
S. Dra̧gan (1996)
Stoichiometry and structure of polyelectrolyte complex particles in diluted solutions
H. Dautzenberg (1996)
Skin as a route of exposure and sensitization in chronic beryllium disease.
S. Tinkle (2003)
Controlled release of FGF-2 using fragmin/protamine microparticles and effect on neovascularization.
S. Nakamura (2009)
Effect of controlled release of fibroblast growth factor-2 from chitosan/fucoidan micro complex-hydrogel on in vitro and in vivo vascularization.
S. Nakamura (2008)
More to "heparin" than anticoagulation.
U. Lindahl (1994)
Soluble polyelectrolyte complexes composed of poly(ethylene oxide)-block-poly(sodium methacrylate) and poly(methacryloyloxyethyl trimethylammonium chloride)
Susanna Holappa (2003)
This paper is referenced by
Low-Molecular Weight Heparin/ProtamineMicro-Nanoparticles Augmented Viability of HumanAdipose-Derived Regenerative Cells
Masashi Sakuma (2018)
Extremophilic polysaccharide nanoparticles for cancer nanotherapy and evaluation of antioxidant properties.
S. Raveendran (2015)
Platelet-rich plasma-containing fragmin-protamine micro-nanoparticles promote epithelialization and angiogenesis in split-thickness skin graft donor sites.
Yūki Takabayashi (2015)
Improved angiogenesis and healing in crush syndrome by fibroblast growth factor-2-containing low-molecular-weight heparin (Fragmin)/protamine nanoparticles.
Makoto Takikawa (2015)
Self-assembled hyaluronate/protamine polyelectrolyte nanoplexes: synthesis, stability, biocompatibility and potential use as peptide carriers.
A. Umerska (2014)
Experimental and Clinical Therapeutic Uses of Low-Molecular-Weight Heparin / Protamine Micro / Nanoparticles
M. Ishihara (2015)
FGF2 and FGFR2 in patients with idiopathic pulmonary fibrosis and lung cancer
L. Li (2018)
Functionalized heparin-protamine based self-assembled nanocomplex for efficient anti-angiogenic therapy.
F. Alam (2015)
Characterization of Highly Heterogeneous Heparin-Protein Complexes Using Novel Mass Spectrometry-Based Approaches
Yunlong Zhao (2017)
Heparin: new life for an old drug.
Carlos Raúl Aláez-Versón (2017)
Temperature-sensitive heparin-modified poloxamer hydrogel with affinity to KGF facilitate the morphologic and functional recovery of the injured rat uterus
He-Lin Xu (2017)
Autologous and heterotopic transplantation of adipose stromal vascular fraction ameliorates stress urinary incontinence in rats with simulated childbirth trauma
K. Inoue (2018)
FGF-2-containing dalteparin/protamine nanoparticles (FGF-2&D/P NPs) ameliorate UV-induced skin photoaging in hairless mice
Yūki Takabayashi (2018)
Polyelectrolyte Complexes of Natural Polymers and Their Biomedical Applications
M. Ishihara (2019)
HEPARINOID-BASED BIOMATERIALS AND THEIR APPLICATIONS
Masayuki Ishihara (2016)
Advanced nanocarriers based on heparin and its derivatives for cancer management.
Xiaoye Yang (2015)
Enhanced effect of fibroblast growth factor-2-containing dalteparin/protamine nanoparticles on hair growth
Yūki Takabayashi (2016)
Chondroitin-based nanoplexes as peptide delivery systems--Investigations into the self-assembly process, solid-state and extended release characteristics.
A. Umerska (2015)
Improvement of Hydrodynamics-Based Gene Transfer of Nonviral DNA Targeted to Murine Hepatocytes
S. Nakamura (2013)
Low-Molecular-Weight Heparin and Protamine-Based Polyelectrolyte Nano Complexes for Protein Delivery (A Review Articles)
M. Ishihara (2011)
Protein-based nanoparticles as a drug delivery system: chances, risks, perspectives
S. Fuchs (2010)
Protective effect of FGF-2 and low-molecular-weight heparin/protamine nanoparticles on radiation-induced healing-impaired wound repair in rats
Jun Kinoda (2018)
Pharmaceutically versatile sulfated polysaccharide based bionano platforms.
S. Raveendran (2013)
Platelet-Rich Plasma Incorporated Nanostructures for Tissue Engineering Applications
Mohammad Amin Shamekhi (2017)
Two-Phase Electrospinning to Incorporate Polyelectrolyte Complexes and Growth Factors into Electrospun Chitosan Nanofibers.
Laura W. Place (2016)
Manufacturing of a Secretoneurin Drug Delivery System with Self-Assembled Protamine Nanoparticles by Titration
B. Scheicher (2016)
Novel Experimental and Clinical Therapeutic Uses of Low-Molecular-Weight Heparin/Protamine Microparticles
S. Kishimoto (2012)
Three-Dimensional Expansion Using Plasma-Medium Gel with Fragmin/Protamine Nanoparticles and FGF-2 to Stimulate Adipose-Derived Stromal Cells and Bone Marrow-Derived Mesenchymal Stem Cells
S. Kishimoto (2012)
A REVIEW ON BIOMEDICAL APPLICATIONS OF CHITOSAN-BASED BIOMATERIALS
M. Ishihara (2015)
Low-Molecular-Weight Heparin and Protamine-Based Polyelectrolyte Nano Complexes for Protein Delivery ( A Review Article )
M. Ishihara (2012)
Biomaterials as cell carriers for augmentation of adipose tissue-derived stromal cell transplantation.
M. Ishihara (2018)
Smart Carriers and Nanohealers: A Nanomedical Insight on Natural Polymers
S. Raveendran (2017)See more